当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2014年第8期 > 正文
编号:12970920
上皮性卵巢癌组织中趋化因子CXCL12及其受体CXCR4的表达及临床意义(2)
http://www.100md.com 2014年8月1日 《特别健康·下半月》2014年第8期
     参考文献

    [1]MULLER A,HOMEY B,SOTO H,et al. Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50256.

    [2]KOSHIBA T,HOSOTANI R,MIYAMOTO Y, et al. Expression of stromal cell-derived factor21 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression[J]..Clin Cancer Res,2000,6(9):353023535.

    [3]Mori T,Doi R,Koizumi M,et al. CXCR4 antagonist inhibits stromal cell - derived factor 1 - induced migration and invasion of human pancreatic cancer [J]. Mol Cancer Ther,2004,3( 1) : 29 - 37.

    [4]Salvucci O,Yao L,Villalba S,et al. Ragulation of endothelial cell branching morphogenesis by endogenous chemokine stromal - derived factor - 1[J]. Blood,2002,99( 8) : 2703 - 2711.

    [5]Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breastcancer metastasis[J].Nature, 2001,410(6824): 50256.

    [6] Balkw ill F. Cancer and the chemokine network [J].Nat Rev Cancer, 2004, 4(7) :540-550.

    [7]Kulbe H,Levinson N R,Balkwill F,et al.The Chemokine Network in Cancer-much More than Directing Cell Movement[J].The International Journal of Developmental Biology,2004,48(5-6):489-496.

    [8]Müller A,Homey B,Soto H,et al.Involvement of Chemokine Receptors in Breast Cancer Metastasis[J].Nature,2001,410(6824):50-56. (刘淑霞)
上一页1 2